Clinical Trials Browser

INDUSTRY × Lymphoma × tisagenlecleucel × Clear all

NCT03601442 2026-04-23

Managed Access Programs for CTL019, Tisagenlecleucel

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT03876028 2023-01-31

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Phase 1 Terminated

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse